Quest Diagnostics (NYSE:DGX) Price Target Raised to $180.00 at Evercore ISI
Quest Diagnostics (NYSE:DGX – Free Report) had its price target raised by Evercore ISI from $175.00 to $180.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an in-line rating on the medical research company’s stock. DGX has been the topic of several other reports. Citigroup lowered shares of Quest Diagnostics from a […]
Quest Diagnostics (NYSE:DGX – Free Report) had its price target raised by Evercore ISI from $175.00 to $180.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an in-line rating on the medical research company’s stock. DGX has been the topic of several other reports. Citigroup lowered shares of Quest Diagnostics from a […]
